How do vaccines work? - Kelwalin Dhanasarnsombut
4:36
YouTubeTED-Ed
How do vaccines work? - Kelwalin Dhanasarnsombut
Learn the science behind how vaccines trigger an immune response and teach our bodies to recognize dangerous pathogens. -- The first ever vaccine was created when Edward Jenner, an English physician and scientist, successfully injected small amounts of a cowpox virus into a young boy to protect him from the related (and deadly) smallpox virus ...
3.4M viewsJan 12, 2015
COVID-19 vaccine COVAX Initiative
First COVID-19 vaccine doses from COVAX arrive in Africa
2:53
First COVID-19 vaccine doses from COVAX arrive in Africa
Global NewsFrancis Kokutse,Carley
Feb 24, 2021
What is COVAX?
1:10
What is COVAX?
ABC NewsMorgan Winsor
Feb 26, 2021
5 Things to Know About COVAX , the Life-Saving Vaccine Initiative
5 Things to Know About COVAX , the Life-Saving Vaccine Initiative
globalcitizen.org
Mar 9, 2021
Top videos
Clinical Skills: Administering Vaccinations
4:33
Clinical Skills: Administering Vaccinations
YouTubeAMBOSS: Medical
1.4M viewsJan 7, 2021
Doctor Answers Vaccine Questions | Tech Support | WIRED
25:17
Doctor Answers Vaccine Questions | Tech Support | WIRED
YouTubeWIRED
279K views3 weeks ago
All Types of Vaccines, How They Work, Animation.
5:55
All Types of Vaccines, How They Work, Animation.
YouTubeAlila Medical Media
637.5K viewsJan 27, 2021
COVID-19 vaccine Breakthrough Infections
1. How mRNA Vaccines and Vaccine Breakthrough Infections Drive Viral Immune Escape Dynamics
1. How mRNA Vaccines and Vaccine Breakthrough Infections Drive Viral Immune Escape Dynamics
rumble.com
1 month ago
What causes breakthrough measles infections even if someone is vaccinated?
1:12
What causes breakthrough measles infections even if someone is vaccinated?
NBC NewsDavid Cox
8 months ago
13K views · 186 reactions | Indian pharma company Zydus has said it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies. Zydus will enrol over 1,000 subjects across multiple clinical study sites in India in the human trials. Vaccines are awaited as coronavirus infections continue to surge in the world's third worst-hit nation. | The Times of India | Facebook
0:37
13K views · 186 reactions | Indian pharma company Zydus has said it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies. Zydus will enrol over 1,000 subjects across multiple clinical study sites in India in the human trials. Vaccines are awaited as coronavirus infections continue to surge in the world's third worst-hit nation. | The Times of India | Facebook
FacebookThe Times of India
13.9K views2 weeks ago